Academic Journal

Myeloablative Fractionated Busulfan Conditioning Regimen with Sorafenib in Patients with AML: Results of Phase I Clinical Trial

التفاصيل البيبلوغرافية
العنوان: Myeloablative Fractionated Busulfan Conditioning Regimen with Sorafenib in Patients with AML: Results of Phase I Clinical Trial
المؤلفون: Popat, Uday R, Mehta, Rohtesh S., Thall, Peter, Bassett, Roland, Alousi, Amin M., Al-Atrash, Gheath, Bashir, Qaiser, Hosing, Chitra, Im, Jin Seon, Kebriaei, Partow, Marin, David, Nieto, Yago, Olson, Amanda, Oran, Betul, Ramdial, Jeremy, Saini, Neeraj Y, Srour, Samer A, Valdez, Ben C., Rezvani, Katayoun, Qazilbash, Muzaffar H., Daver, Naval, Ravandi, Farhad, Shpall, Elizabeth J, Champlin, Richard E, Andersson, Borje S.
المصدر: Transplantation and Cellular Therapy ; volume 28, issue 3, page S78-S79 ; ISSN 2666-6367
بيانات النشر: Elsevier BV
سنة النشر: 2022
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/s2666-6367(22)00252-4
الاتاحة: http://dx.doi.org/10.1016/s2666-6367(22)00252-4
https://api.elsevier.com/content/article/PII:S2666636722002524?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2666636722002524?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/
رقم الانضمام: edsbas.C9CD6CFF
قاعدة البيانات: BASE
الوصف
DOI:10.1016/s2666-6367(22)00252-4